Table of Content 1 Introduction 1.1 Objective of the Study 1.2 Definition of the Market 1.3 Market Scope 1.3.1 Market Segment by Type, Application and Marketing Channel 1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa) 1.4 Years Considered for the Study (2014-2026) 1.5 Currency Considered (U.S. Dollar) 1.6 Stakeholders 2 Key Findings of the Study 3 Market Dynamics 3.1 Driving Factors for this Market 3.2 Factors Challenging the Market 3.3 Opportunities of the Global Nephropathy Medicine Market (Regions, Growing/Emerging Downstream Market Analysis) 3.4 Technological and Market Developments in the Nephropathy Medicine Market 3.5 Industry News by Region 3.6 Regulatory Scenario by Region/Country 3.7 Market Investment Scenario Strategic Recommendations Analysis 4 Value Chain of the Nephropathy Medicine Market 4.1 Value Chain Status 4.2 Upstream Raw Material Analysis 4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type) 4.4 Distributors/Traders 4.5 Downstream Major Customer Analysis (by Region) 5 Global Nephropathy Medicine Market-Segmentation by Type 5.1 Prescription medicine 5.2 OTC 6 Global Nephropathy Medicine Market-Segmentation by Application 6.1 Inflammation 6.2 Calculus 6.3 Renal cyst 6.4 Diabetic nephropathy 6.5 Others 7 Global Nephropathy Medicine Market-Segmentation by Marketing Channel 7.1 Traditional Marketing Channel (Offline) 7.2 Online Channel 8 Competitive Intelligence – Company Profiles 8.1 Alnylam 8.1.1 Alnylam Profile 8.1.2 Alnylam Sales, Growth Rate and Global Market Share from 2014-2019E 8.1.3 Alnylam Product/Solution Launches and Enhancements Analysis 8.1.4 Alnylam Business Overview/Recent Development/Acquisitions 8.2 Novartis 8.2.1 Novartis Profile 8.2.2 Novartis Sales, Growth Rate and Global Market Share from 2014-2019E 8.2.3 Novartis Product/Solution Launches and Enhancements Analysis 8.2.4 Novartis Business Overview/Recent Development/Acquisitions 8.3 Biogen Idec 8.3.1 Biogen Idec Profile 8.3.2 Biogen Idec Sales, Growth Rate and Global Market Share from 2014-2019E 8.3.3 Biogen Idec Product/Solution Launches and Enhancements Analysis 8.3.4 Biogen Idec Business Overview/Recent Development/Acquisitions 8.4 Genzyme Corporation 8.4.1 Genzyme Corporation Profile 8.4.2 Genzyme Corporation Sales, Growth Rate and Global Market Share from 2014-2019E 8.4.3 Genzyme Corporation Product/Solution Launches and Enhancements Analysis 8.4.4 Genzyme Corporation Business Overview/Recent Development/Acquisitions 8.5 BioTime 8.5.1 BioTime Profile 8.5.2 BioTime Sales, Growth Rate and Global Market Share from 2014-2019E 8.5.3 BioTime Product/Solution Launches and Enhancements Analysis 8.5.4 BioTime Business Overview/Recent Development/Acquisitions 8.6 Abbott 8.6.1 Abbott Profile 8.6.2 Abbott Sales, Growth Rate and Global Market Share from 2014-2019E 8.6.3 Abbott Product/Solution Launches and Enhancements Analysis 8.6.4 Abbott Business Overview/Recent Development/Acquisitions 8.7 Astrazeneca 8.7.1 Astrazeneca Profile 8.7.2 Astrazeneca Sales, Growth Rate and Global Market Share from 2014-2019E 8.7.3 Astrazeneca Product/Solution Launches and Enhancements Analysis 8.7.4 Astrazeneca Business Overview/Recent Development/Acquisitions 8.8 Shionogi Inc. 8.8.1 Shionogi Inc. Profile 8.8.2 Shionogi Inc. Sales, Growth Rate and Global Market Share from 2014-2019E 8.8.3 Shionogi Inc. Product/Solution Launches and Enhancements Analysis 8.8.4 Shionogi Inc. Business Overview/Recent Development/Acquisitions 8.9 Sanofi-aventis 8.9.1 Sanofi-aventis Profile 8.9.2 Sanofi-aventis Sales, Growth Rate and Global Market Share from 2014-2019E 8.9.3 Sanofi-aventis Product/Solution Launches and Enhancements Analysis 8.9.4 Sanofi-aventis Business Overview/Recent Development/Acquisitions 8.10 Roche 8.10.1 Roche Profile 8.10.2 Roche Sales, Growth Rate and Global Market Share from 2014-2019E 8.10.3 Roche Product/Solution Launches and Enhancements Analysis 8.10.4 Roche Business Overview/Recent Development/Acquisitions 8.11 Bayer 8.11.1 Bayer Profile 8.11.2 Bayer Sales, Growth Rate and Global Market Share from 2014-2019E 8.11.3 Bayer Product/Solution Launches and Enhancements Analysis 8.11.4 Bayer Business Overview/Recent Development/Acquisitions 8.12 Lilly 8.12.1 Lilly Profile 8.12.2 Lilly Sales, Growth Rate and Global Market Share from 2014-2019E 8.12.3 Lilly Product/Solution Launches and Enhancements Analysis 8.12.4 Lilly Business Overview/Recent Development/Acquisitions 9 Global Nephropathy Medicine Market-Segmentation by Geography 10 North America 10.1 North America Nephropathy Medicine Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 10.2 North America Nephropathy Medicine Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 10.3 North America Nephropathy Medicine Production Analysis from 2014-2019E 10.4 North America Nephropathy Medicine Consumption Analysis from 2014-2019E 10.5 North America Nephropathy Medicine Import and Export from 2014-2019E 10.6 North America Nephropathy Medicine Value, Production and Market Share by Type (2014-2019E) 10.7 North America Nephropathy Medicine Consumption, Value and Market Share by Application (2014-2019E) 10.8 North America Nephropathy Medicine by Country (United States, Canada) 10.8.1 North America Nephropathy Medicine Sales by Country (2014-2019E) 10.8.2 North America Nephropathy Medicine Consumption Value by Country (2014-2019E) 10.9 North America Nephropathy Medicine Market PEST Analysis 11 Europe 11.1 Europe Nephropathy Medicine Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 11.2 Europe Nephropathy Medicine Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 11.3 Europe Nephropathy Medicine Production Analysis from 2014-2019E 11.4 Europe Nephropathy Medicine Consumption Analysis from 2014-2019E 11.5 Europe Nephropathy Medicine Import and Export from 2014-2019E 11.6 Europe Nephropathy Medicine Value, Production and Market Share by Type (2014-2019E) 11.7 Europe Nephropathy Medicine Consumption, Value and Market Share by Application (2014-2019E) 11.8 Europe Nephropathy Medicine by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium) 11.8.1 Europe Nephropathy Medicine Sales by Country (2014-2019E) 11.8.2 Europe Nephropathy Medicine Consumption Value by Country (2014-2019E) 11.9 Europe Nephropathy Medicine Market PEST Analysis 12 Asia-Pacific 12.1 Asia-Pacific Nephropathy Medicine Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 12.2 Asia-Pacific Nephropathy Medicine Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 12.3 Asia-Pacific Nephropathy Medicine Production Analysis from 2014-2019E 12.4 Asia-Pacific Nephropathy Medicine Consumption Analysis from 2014-2019E 12.5 Asia-Pacific Nephropathy Medicine Import and Export from 2014-2019E 12.6 Asia-Pacific Nephropathy Medicine Value, Production and Market Share by Type (2014-2019E) 12.7 Asia-Pacific Nephropathy Medicine Consumption, Value and Market Share by Application (2014-2019E) 12.8 Asia-Pacific Nephropathy Medicine by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia) 12.8.1 Asia-Pacific Nephropathy Medicine Sales by Country (2014-2019E) 12.8.2 Asia-Pacific Nephropathy Medicine Consumption Value by Country (2014-2019E) 12.9 Asia-Pacific Nephropathy Medicine Market PEST Analysis 13 Latin America 13.1 Latin America Nephropathy Medicine Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 13.2 Latin America Nephropathy Medicine Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 13.3 Latin America Nephropathy Medicine Production Analysis from 2014-2019E 13.4 Latin America Nephropathy Medicine Consumption Analysis from 2014-2019E 13.5 Latin America Nephropathy Medicine Import and Export from 2014-2019E 13.6 Latin America Nephropathy Medicine Value, Production and Market Share by Type (2014-2019E) 13.7 Latin America Nephropathy Medicine Consumption, Value and Market Share by Application (2014-2019E) 13.8 Latin America Nephropathy Medicine by Country (Brazil, Mexico, Argentina, Columbia, Chile) 13.8.1 Latin America Nephropathy Medicine Sales by Country (2014-2019E) 13.8.2 Latin America Nephropathy Medicine Consumption Value by Country (2014-2019E) 13.9 Latin America Nephropathy Medicine Market PEST Analysis 14 Middle East & Africa 14.1 Middle East & Africa Nephropathy Medicine Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 14.2 Middle East & Africa Nephropathy Medicine Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 14.3 Middle East & Africa Nephropathy Medicine Production Analysis from 2014-2019E 14.4 Middle East & Africa Nephropathy Medicine Consumption Analysis from 2014-2019E 14.5 Middle East & Africa Nephropathy Medicine Import and Export from 2014-2019E 14.6 Middle East & Africa Nephropathy Medicine Value, Production and Market Share by Type (2014-2019E) 14.7 Middle East & Africa Nephropathy Medicine Consumption, Value and Market Share by Application (2014-2019E) 14.8 Middle East & Africa Nephropathy Medicine by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa) 14.8.1 Middle East & Africa Nephropathy Medicine Sales by Country (2014-2019E) 14.8.2 Middle East & Africa Nephropathy Medicine Consumption Value by Country (2014-2019E) 14.9 Middle East & Africa Nephropathy Medicine Market PEST Analysis 15 Future Forecast of the Global Nephropathy Medicine Market from 2018-2026 15.1 Future Forecast of the Global Nephropathy Medicine Market from 2019-2026 Segment by Region 15.2 Global Nephropathy Medicine Production and Growth Rate Forecast by Type (2019-2026) 15.3 Global Nephropathy Medicine Consumption and Growth Rate Forecast by Application (2019-2026) 16 Appendix 16.1 Methodology 16.2 Research Data Source

List of Tables and Figures Global Nephropathy Medicine Market Value ($) and Growth Rate of Nephropathy Medicine from 2014-2026 Global Nephropathy Medicine Production and Growth Rate Segment by Product Type from 2014-2026F Global Nephropathy Medicine Consumption and Growth Rate Segment by Application from 2014-2019E Figure Nephropathy Medicine Picture Table Product Specifications of Nephropathy Medicine Table Driving Factors for this Market Table Industry News of Nephropathy Medicine Market Figure Value Chain Status of Nephropathy Medicine Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type) Table Distributors/Traders Table Downstream Major Customer Analysis (by Region, by Preference) Table Global Nephropathy Medicine Production and Growth Rate Segment by Product Type from 2014-2019E Table Global Nephropathy Medicine Value ($) and Growth Rate Segment by Product Type from 2014-2019E Figure Prescription medicine of Nephropathy Medicine Figure OTC of Nephropathy Medicine Table Global Nephropathy Medicine Consumption and Growth Rate Segment by Application from 2014-2019E Table Global Nephropathy Medicine Value ($) and Growth Rate Segment by Application from 2014-2019E Figure Inflammation of Nephropathy Medicine Figure Calculus of Nephropathy Medicine Figure Renal cyst of Nephropathy Medicine Figure Diabetic nephropathy of Nephropathy Medicine Figure Others of Nephropathy Medicine Table Global Nephropathy Medicine Consumption and Growth Rate Segment by Marketing Channel from 2014-2019E Table Global Nephropathy Medicine Value ($) and Growth Rate Segment by Marketing Channel from 2014-2019E Figure Traditional Marketing Channel (Offline) of Nephropathy Medicine Figure Online Channel of Nephropathy Medicine Table Alnylam Profile (Company Name, Plants Distribution, Sales Region) Figure Alnylam Sales and Growth Rate from 2014-2019E Figure Alnylam Revenue ($) and Global Market Share from 2014-2019E Table Alnylam Nephropathy Medicine Sales, Price, Revenue, Gross Margin (2014-2019E) Table Novartis Profile (Company Name, Plants Distribution, Sales Region) Figure Novartis Sales and Growth Rate from 2014-2019E Figure Novartis Revenue ($) and Global Market Share from 2014-2019E Table Novartis Nephropathy Medicine Sales, Price, Revenue, Gross Margin (2014-2019E) Table Biogen Idec Profile (Company Name, Plants Distribution, Sales Region) Figure Biogen Idec Sales and Growth Rate from 2014-2019E Figure Biogen Idec Revenue ($) and Global Market Share from 2014-2019E Table Biogen Idec Nephropathy Medicine Sales, Price, Revenue, Gross Margin (2014-2019E) Table Genzyme Corporation Profile (Company Name, Plants Distribution, Sales Region) Figure Genzyme Corporation Sales and Growth Rate from 2014-2019E Figure Genzyme Corporation Revenue ($) and Global Market Share from 2014-2019E Table Genzyme Corporation Nephropathy Medicine Sales, Price, Revenue, Gross Margin (2014-2019E) Table BioTime Profile (Company Name, Plants Distribution, Sales Region) Figure BioTime Sales and Growth Rate from 2014-2019E Figure BioTime Revenue ($) and Global Market Share from 2014-2019E Table BioTime Nephropathy Medicine Sales, Price, Revenue, Gross Margin (2014-2019E) Table Abbott Profile (Company Name, Plants Distribution, Sales Region) Figure Abbott Sales and Growth Rate from 2014-2019E Figure Abbott Revenue ($) and Global Market Share from 2014-2019E Table Abbott Nephropathy Medicine Sales, Price, Revenue, Gross Margin (2014-2019E) Table Astrazeneca Profile (Company Name, Plants Distribution, Sales Region) Figure Astrazeneca Sales and Growth Rate from 2014-2019E Figure Astrazeneca Revenue ($) and Global Market Share from 2014-2019E Table Astrazeneca Nephropathy Medicine Sales, Price, Revenue, Gross Margin (2014-2019E) Table Shionogi Inc. Profile (Company Name, Plants Distribution, Sales Region) Figure Shionogi Inc. Sales and Growth Rate from 2014-2019E Figure Shionogi Inc. Revenue ($) and Global Market Share from 2014-2019E Table Shionogi Inc. Nephropathy Medicine Sales, Price, Revenue, Gross Margin (2014-2019E) Table Sanofi-aventis Profile (Company Name, Plants Distribution, Sales Region) Figure Sanofi-aventis Sales and Growth Rate from 2014-2019E Figure Sanofi-aventis Revenue ($) and Global Market Share from 2014-2019E Table Sanofi-aventis Nephropathy Medicine Sales, Price, Revenue, Gross Margin (2014-2019E) Table Roche Profile (Company Name, Plants Distribution, Sales Region) Figure Roche Sales and Growth Rate from 2014-2019E Figure Roche Revenue ($) and Global Market Share from 2014-2019E Table Roche Nephropathy Medicine Sales, Price, Revenue, Gross Margin (2014-2019E) Table Bayer Profile (Company Name, Plants Distribution, Sales Region) Figure Bayer Sales and Growth Rate from 2014-2019E Figure Bayer Revenue ($) and Global Market Share from 2014-2019E Table Bayer Nephropathy Medicine Sales, Price, Revenue, Gross Margin (2014-2019E) Table Lilly Profile (Company Name, Plants Distribution, Sales Region) Figure Lilly Sales and Growth Rate from 2014-2019E Figure Lilly Revenue ($) and Global Market Share from 2014-2019E Table Lilly Nephropathy Medicine Sales, Price, Revenue, Gross Margin (2014-2019E) Table Global Nephropathy Medicine Production Value ($) by Region from 2014-2019E Table Global Nephropathy Medicine Production Value Share by Region from 2014-2019E Table Global Nephropathy Medicine Production by Region from 2014-2019E Table Global Nephropathy Medicine Consumption Value ($) by Region from 2014-2019E Table Global Nephropathy Medicine Consumption by Region from 2014-2019E Table North America Nephropathy Medicine Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table North America Nephropathy Medicine Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table North America Nephropathy Medicine Import and Export from 2014-2019E Table North America Nephropathy Medicine Value ($) by Type (2014-2019E) Table North America Nephropathy Medicine Production by Type (2014-2019E) Table North America Nephropathy Medicine Consumption by Application (2014-2019E) Table North America Nephropathy Medicine Consumption by Country (2014-2019E) Table North America Nephropathy Medicine Consumption Value ($) by Country (2014-2019E) Figure North America Nephropathy Medicine Market PEST Analysis Table Europe Nephropathy Medicine Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Europe Nephropathy Medicine Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Europe Nephropathy Medicine Import and Export from 2014-2019E Table Europe Nephropathy Medicine Value ($) by Type (2014-2019E) Table Europe Nephropathy Medicine Production by Type (2014-2019E) Table Europe Nephropathy Medicine Consumption by Application (2014-2019E) Table Europe Nephropathy Medicine Consumption by Country (2014-2019E) Table Europe Nephropathy Medicine Consumption Value ($) by Country (2014-2019E) Figure Europe Nephropathy Medicine Market PEST Analysis Table Asia-Pacific Nephropathy Medicine Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Asia-Pacific Nephropathy Medicine Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Asia-Pacific Nephropathy Medicine Import and Export from 2014-2019E Table Asia-Pacific Nephropathy Medicine Value ($) by Type (2014-2019E) Table Asia-Pacific Nephropathy Medicine Production by Type (2014-2019E) Table Asia-Pacific Nephropathy Medicine Consumption by Application (2014-2019E) Table Asia-Pacific Nephropathy Medicine Consumption by Country (2014-2019E) Table Asia-Pacific Nephropathy Medicine Consumption Value ($) by Country (2014-2019E) Figure Asia-Pacific Nephropathy Medicine Market PEST Analysis Table Latin America Nephropathy Medicine Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Latin America Nephropathy Medicine Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Latin America Nephropathy Medicine Import and Export from 2014-2019E Table Latin America Nephropathy Medicine Value ($) by Type (2014-2019E) Table Latin America Nephropathy Medicine Production by Type (2014-2019E) Table Latin America Nephropathy Medicine Consumption by Application (2014-2019E) Table Latin America Nephropathy Medicine Consumption by Country (2014-2019E) Table Latin America Nephropathy Medicine Consumption Value ($) by Country (2014-2019E) Figure Latin America Nephropathy Medicine Market PEST Analysis Table Middle East & Africa Nephropathy Medicine Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Middle East & Africa Nephropathy Medicine Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Middle East & Africa Nephropathy Medicine Import and Export from 2014-2019E Table Middle East & Africa Nephropathy Medicine Value ($) by Type (2014-2019E) Table Middle East & Africa Nephropathy Medicine Production by Type (2014-2019E) Table Middle East & Africa Nephropathy Medicine Consumption by Application (2014-2019E) Table Middle East & Africa Nephropathy Medicine Consumption by Country (2014-2019E) Table Middle East & Africa Nephropathy Medicine Consumption Value ($) by Country (2014-2019E) Figure Middle East & Africa Nephropathy Medicine Market PEST Analysis Table Global Nephropathy Medicine Value ($) and Growth Rate Forecast by Region (2018-2026) Table Global Nephropathy Medicine Production and Growth Rate Forecast by Region (2019-2026) Table Global Nephropathy Medicine Consumption and Growth Rate Forecast by Region (2019-2026) Table Global Nephropathy Medicine Production and Growth Rate Forecast by Type (2019-2026) Table Global Nephropathy Medicine Consumption and Growth Rate Forecast by Application (2019-2026)